Literature DB >> 7996962

Greatly increased luminal nitric oxide in ulcerative colitis.

J O Lundberg1, P M Hellström, J M Lundberg, K Alving.   

Abstract

A role for nitric oxide (NO) in ulcerative colitis has been suggested because mucosal NO synthase activity, measured by indirect assays, is increased in this disorder. We directly measured luminal NO in the colons of twelve controls and six patients with active ulcerative colitis. During colonoscopy, gas was aspirated from different parts of the colon and immediately analysed by a chemiluminescence technique. NO concentrations were more than 100 times higher in the patients than in the controls. Luminal NO is rapidly and easily measurable and may be used to monitor inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7996962     DOI: 10.1016/s0140-6736(94)90460-x

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  71 in total

Review 1.  Nasal nitric oxide in man.

Authors:  J O Lundberg; E Weitzberg
Journal:  Thorax       Date:  1999-10       Impact factor: 9.139

Review 2.  Small therapeutic molecules for the treatment of inflammatory bowel disease.

Authors:  S J H van Deventer
Journal:  Gut       Date:  2002-05       Impact factor: 23.059

Review 3.  A review of the efficacy of traditional Iranian medicine for inflammatory bowel disease.

Authors:  Roja Rahimi; Mohammad Reza Shams-Ardekani; Mohammad Abdollahi
Journal:  World J Gastroenterol       Date:  2010-09-28       Impact factor: 5.742

Review 4.  Nitrate, nitrite and nitric oxide reductases: from the last universal common ancestor to modern bacterial pathogens.

Authors:  Andrés Vázquez-Torres; Andreas J Bäumler
Journal:  Curr Opin Microbiol       Date:  2015-09-29       Impact factor: 7.934

5.  Measurement of Fractional Exhaled Nitric Oxide as a Marker of Disease Activity in Inflammatory Bowel Disease.

Authors:  Erkanda Ikonomi; Robin D Rothstein; Adam C Ehrlich; Frank K Friedenberg
Journal:  J Gastroenterol Pancreatol Liver Disord       Date:  2016-01-27

6.  Rectal nitric oxide as biomarker in the treatment of inflammatory bowel disease: responders versus nonresponders.

Authors:  Tryggve Ljung; Sofie Lundberg; Mark Varsanyi; Catharina Johansson; Peter T Schmidt; Max Herulf; Jon O Lundberg; Per M Hellstrom
Journal:  World J Gastroenterol       Date:  2006-06-07       Impact factor: 5.742

7.  Expression of apoptotic epithelial cells within lamina propria beneath the basement membrane triggers dextran sulfate sodium-induced colitis.

Authors:  Kazuko Shichijo; Makoto Ihara; Mohammed Shawkat Razzaque; Mutsumi Matsuu-Matsuyama; Toshiyuki Nakayama; Masahiro Nakashima; Ichiro Sekine
Journal:  Dig Dis Sci       Date:  2008-02-01       Impact factor: 3.199

Review 8.  Fibrogenesis and fibrosis in inflammatory bowel diseases: Good and bad side of same coin?

Authors:  Mariabeatrice Principi; Floriana Giorgio; Giuseppe Losurdo; Viviana Neve; Antonella Contaldo; Alfredo Di Leo; Enzo Ierardi
Journal:  World J Gastrointest Pathophysiol       Date:  2013-11-15

9.  Nitric oxide increases Wnt-induced secreted protein-1 (WISP-1/CCN4) expression and function in colitis.

Authors:  Hongying Wang; Rui Zhang; Shoubin Wen; Donna-Marie McCafferty; Paul L Beck; Wallace K MacNaughton
Journal:  J Mol Med (Berl)       Date:  2009-02-24       Impact factor: 4.599

10.  Expression of apoptosis-related proteins in rat with induced colitis.

Authors:  Giuseppe D'Argenio; Maria Grazia Farrace; Vittorio Cosenza; Francesca De Ritis; Nicola Della Valle; Francesco Manguso; Mauro Piacentini
Journal:  Int J Colorectal Dis       Date:  2004-04-09       Impact factor: 2.571

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.